Document Detail

Bivalirudin use in patients undergoing percutaneous coronary intervention for acute myocardial infarction. Insights from the prospective, multi-centre EUROVISION registry.
MedLine Citation:
PMID:  25101656     Owner:  NLM     Status:  Publisher    
Background: The effectiveness of bivalirudin in patients undergoing percutaneous coronary intervention for acute myocardial infarction has been tested in clinical trials, but its use in a real-world scenario has never been reported. Methods: From the total number of patients enrolled in the EUROVISION registry, 678 subjects affected by ST-elevation myocardial infarction were selected and included in the analysis. Posology and usage patterns of bivalirudin, as evaluated by dose and time of drug bolus and infusion administered, were evaluated. The 30-day outcome has been assessed by efficacy and safety endpoints. Results: All patients received an initial intravenous bolus of bivalirudin (0.70 ± 0.25 mg/kg) followed by an infusion (1.58 ± 0.47 mg/kg/h; duration: 60 [30, 107] min) in 99.3% of cases. An additional bolus (0.49 ± 0.06 mg/kg) was administered in 9.3% of patients. Bivalirudin infusion was prolonged after procedure in 62.2%. Death occurred in 2.1% of patients, non-fatal myocardial reinfarction in 0.3%, unplanned revascularization in 0.6% and non-fatal stroke in 0.4%. Acute stent thrombosis was not observed. Major bleeding occurred in 1.5% of patients. Conclusions: Bivalirudin usage in the setting of primary PCI provided excellent results in terms of 30-day outcome even in a real-world population.
U Limbruno; A Picchi; S Galli; K Huber; J Lipiecki; D Bernstein; E Deliargyris; P Anthopoulos; C Nienaber; M Hamon
Related Documents :
24755126 - Warfarin compared with aspirin for older chinese patients with stable coronary heart di...
23392056 - Correlates of impaired global right ventricular function in patients with a reperfused ...
23273716 - Prognostic value of neutrophil to lymphocyte ratio in patients presenting with st-eleva...
23160976 - Impact of cardiac rehabilitation exercise program on left ventricular diastolic functio...
16158356 - Flocor (cytrx corp).
860696 - Pathogenesis of an unexpected sudden death: role of early cycle ventricular premature c...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-8-7
Journal Detail:
Title:  Acute cardiac care     Volume:  -     ISSN:  1748-295X     ISO Abbreviation:  Acute Card Care     Publication Date:  2014 Aug 
Date Detail:
Created Date:  2014-8-7     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101276603     Medline TA:  Acute Card Care     Country:  -    
Other Details:
Languages:  ENG     Pagination:  1-5     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Recurrent takotsubo syndrome in a patient with myotonic dystrophy 1.
Next Document:  Sortilin and lipoprotein metabolism: making sense out of complexity.